miR‑199b‑5p inhibits triple negative breast cancer cell proliferation, migration and invasion by targeting DDR1

Wu,Anhao; Chen,Yan; Liu,Yang; Lai,Yafang; Liu,Dequan

doi:10.3892/ol.2018.9255

miR‑199b‑5p inhibits triple negative breast cancer cell proliferation, migration and invasion by targeting DDR1

Authors:
- Anhao Wu
- Yan Chen
- Yang Liu
- Yafang Lai
- Dequan Liu
View Affiliations

Affiliations: Department of Breast Surgery Ward I, The Third Affiliated Hospital, Kunming Medical University, Tumor Hospital of Yunnan Kunming Province, Kunming, Yunnan 650100, P.R. China, Cancer Institute, Third Affiliated Hospital, Kunming Medical University, Tumor Hospital of Yunnan Kunming Province, Kunming, Yunnan 650100, P.R. China, Public Health, Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China
Published online on: August 2, 2018 https://doi.org/10.3892/ol.2018.9255
Pages: 4889-4896
Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Triple negative breast cancer (TNBC) has received increasing attention from oncologists worldwide due to its poor prognosis and paucity of targeted therapies. MicroRNAs (miRs) are a group of small non‑coding RNAs that are responsible for the post‑transcriptional regulation of various target genes. The present study demonstrated that the expression of miR‑199b‑5p in breast cancer tissue was significantly reduced compared with that in normal breast tissues by reverse transcription‑quantitative polymerase chain reaction. In addition, western blot analysis and luciferase reporter assays revealed that miR‑199b‑5p in TNBC cells inhibited discoidin domain receptor tyrosine kinase 1 expression by directly targeting its 3'‑untranslated region. Furthermore, miR‑199b‑5p markedly suppressed the proliferation and invasion of TNBC cells, as demonstrated by using wound‑healing, migration, invasion and proliferation assays. Collectively, these results indicate that miR‑199b‑5p may be a novel alternative therapeutic target for TNBC.

View Figures

View References

1	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
2	Zeng H, Zhang Z, Dai X, Chen Y, Ye J and Jin Z: Increased expression of microRNA-199b-5p associates with poor prognosis through promoting cell proliferation, invasion and migration abilities of human osteosarcoma. Pathol Oncol Res. 22:253–260. 2016. View Article : Google Scholar : PubMed/NCBI
3	Fang C, Zhao Y and Guo B: MiR-199b-5p targets HER2 in breast cancer cells. J Cell Biochem. 114:1457–1463. 2013. View Article : Google Scholar : PubMed/NCBI
4	Fang C, Wang FB, Li Y and Zeng XT: Down-regulation of miR-199b-5p is correlated with poor prognosis for breast cancer patients. Biomed Pharmacother. 84:1189–1193. 2016. View Article : Google Scholar : PubMed/NCBI
5	Wu X, Weng L, Li X, Guo C, Pal SK, Jin JM, Li Y, Nelson RA, Mu B, Onami SH, et al: Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis. PLoS One. 7:e356612012. View Article : Google Scholar : PubMed/NCBI
6	Favreau AJ, McGlauflin RE, Duarte CW and Sathyanarayana P: miR-199b, a novel tumor suppressor miRNA in acute myeloid leukemia with prognostic implications. Exp Hematol Oncol. 5:42016. View Article : Google Scholar : PubMed/NCBI
7	Wang C, Song B, Song W, Liu J, Sun A, Wu D, Yu H, Lian J, Chen L and Han J: Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients. J Gastroenterol Hepatol. 26:1630–1637. 2011. View Article : Google Scholar : PubMed/NCBI
8	Navrátil J, Fabian P, Palácová M, Petráková K, Vyzula R and Svoboda M: Triple negative breast cancer. Klin Onkol. 28:405–415. 2015.(In Czech). View Article : Google Scholar : PubMed/NCBI
9	Yoshimura T, Matsuyama W and Kamohara H: Discoidin domain receptor 1: A new class of receptor regulating leukocyte-collagen interaction. Immunol Res. 31:219–230. 2005. View Article : Google Scholar : PubMed/NCBI
10	Turashvili G, Bouchal J, Baumforth K, Wei W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J, Srovnal J, et al: Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer. 7:552007. View Article : Google Scholar : PubMed/NCBI
11	Neuhaus B, Bühren S, Böck B, Alves F, Vogel WF and Kiefer F: Migration inhibition of mammary epithelial cells by Sky is blocked in the presence of DDR1 receptors. Cell Mol Life Sci. 68:3757–3770. 2011. View Article : Google Scholar : PubMed/NCBI
12	Quan J, Yahata T, Adachi S, Yoshihara K and Tanaka K: Identification of receptor tyrosine kinase, discoidin domain receptor 1 (DDRl), as a potential biomarker for serous ovarian cancer. Int J Mol Sci. 12:971–982. 2011. View Article : Google Scholar : PubMed/NCBI
13	Colas E, Perez C, Cabrera S, Pedrola N, Monge M, Castellvi J, Eyzaguirre F, Gregorio J, Ruiz A, Llaurado M, et al: Molecular markers of endometrial carcinoma detected in uterine aspirates. Int J Cancer. 129:2435–2444. 2011. View Article : Google Scholar : PubMed/NCBI
14	Nemoto T, Ohashi K, Akashi T, Johnson JD and Hirokawa K: Overexpression of protein tyrosine kinases in human esophageal cancer. Pathobiology. 65:195–203. 1997. View Article : Google Scholar : PubMed/NCBI
15	Valencia K, Ormazábal C, Zandueta C, Luis-Ravelo D, Antón I, Pajares MJ, Agorreta J, Montuenga LM, Martínez-Canarias S, Leitinger B and Lecanda F: Inhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasis. Clin Cancer Res. 18:969–980. 2012. View Article : Google Scholar : PubMed/NCBI
16	Das S, Ongusaha PP, Yang YS, Park JM, Aaronson SA and Lee SW: Discoidin domain receptor 1 receptor tyrosine kinase induces cyclooxygenase-2 and promotes chemoresistance through nuclear factor-kappaB pathway activation. Cancer Res. 66:8123–8130. 2006. View Article : Google Scholar : PubMed/NCBI
17	Park HS, Kim KR, Lee HJ, Choi HN, Kim DK, Kim BT and Moon WS: Overexpression of discoidin domain receptor 1 increases the migration and invasion of hepatocellular carcinoma cells in association with matrix metalloproteinase. Oncol Rep. 18:1435–1441. 2007.PubMed/NCBI
18	Ram R, Lorente G, Nikolich K, Urfer R, Foehr E and Nagavarapu U: Discoidin domain receptor-1a (DDR1a) promotes glioma cell invasion and adhesion in association with matrix metalloproteinase-2. J Neurooncol. 76:239–248. 2006. View Article : Google Scholar : PubMed/NCBI
19	Shen Q, Cicinnati VR, Zhang X, Iacob S, Weber F, Sotiropoulos GC, Radtke A, Lu M, Paul A, Gerken G and Beckebaum S: Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion. Mol Cancer. 9:2272010. View Article : Google Scholar : PubMed/NCBI
20	Toy KA, Valiathan RR, Núñez F, Kidwell KM, Gonzalez ME, Fridman R and Kleer CG: Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer. Breast Cancer Res Treat. 150:9–18. 2015. View Article : Google Scholar : PubMed/NCBI
21	Duncan JS, Whittle MC, Nakamura K, Abell AN, Midland AA, Zawistowski JS, Johnson NL, Granger DA, Jordan NV, Darr DB, et al: Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer. Cell. 149:307–321. 2012. View Article : Google Scholar : PubMed/NCBI
22	Marcotte R, Brown KR, Suarez F, Sayad A, Karamboulas K, Krzyzanowski PM, Sircoulomb F, Medrano M, Fedyshyn Y, Koh JLY, et al: Essential gene profiles in breast, pancreatic, and ovarian cancer cells. Cancer Discov. 2:172–189. 2012. View Article : Google Scholar : PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
24	Chalmin F, Ladoire S, Mignot G, Vincent J, Bruchard M, Remy-Martin JP, Boireau W, Rouleau A, Simon B, Lanneau D, et al: Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest. 120:457–471. 2010.PubMed/NCBI
25	Ebert MS and Sharp PA: MicroRNA sponges: Progresss and possibilities. RNA. 16:2043–2050. 2010. View Article : Google Scholar : PubMed/NCBI